ABC multidrug transporters in schistosomes and other parasitic flatworms

Parasitology International

Volumn 62, Issue 6, 2013, Pages 647-653

  Greenberg, Robert M ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

ABC transporters; Drug resistance; P Glycoprotein; Schistosoma

Indexed keywords

ABC TRANSPORTER; BREAST CANCER RESISTANCE PROTEIN; DEXVERAPAMIL; HYCANTHONE; METHOTREXATE; MULTIDRUG RESISTANCE PROTEIN; MULTIDRUG RESISTANCE PROTEIN 1; NIFEDIPINE; OXAMNIQUINE; PRAZIQUANTEL; TRICLABENDAZOLE; VERAPAMIL;

DRUG SENSITIVITY; EGG PRODUCTION; GENE; HUMAN; IMMUNOREACTIVITY; MULTIDRUG RESISTANCE; MULTIGENE FAMILY; PHYLOGENY; PLATYHELMINTH; PRIORITY JOURNAL; REVIEW; SCHISTOSOMA; SCHISTOSOMA JAPONICUM; SCHISTOSOMA MANSONI; ANIMAL; CHEMICAL STRUCTURE; DRUG EFFECTS; DRUG RESISTANCE; GENETICS; HELMINTHIASIS; METABOLISM; PARASITOLOGY; PHYSIOLOGY; PROTEIN TERTIARY STRUCTURE; SCHISTOSOMIASIS;

METAZOA; PLATYHELMINTHES; SCHISTOSOMA; VERMES;

ANIMALS; ATP-BINDING CASSETTE TRANSPORTERS; DRUG RESISTANCE; HELMINTHIASIS; MODELS, MOLECULAR; P-GLYCOPROTEIN; PLATYHELMINTHS; PROTEIN STRUCTURE, TERTIARY; SCHISTOSOMA; SCHISTOSOMIASIS;

EID: 84885372313     PISSN: 13835769     EISSN: 18730329     Source Type: Journal    
DOI: 10.1016/j.parint.2013.02.006     Document Type: Review

References (113)

1. van der Werf M.J., de Vlas S.J., Brooker S., Looman C.W., Nagelkerke N.J., Habbema J.D., et al. Quantification of clinical morbidity associated with schistosome infection in sub-Saharan Africa. Acta Tropica 2003, 86:125-139.
2. King C.H. Parasites and poverty: the case of schistosomiasis. Acta Tropica 2010, 113:95-104.
3. Hotez P.J., Fenwick A. Schistosomiasis in Africa: an emerging tragedy in our new global health decade. PLoS Neglected Tropical Diseases 2009, 3:e485.
4. King C.H., Dangerfield-Cha M. The unacknowledged impact of chronic schistosomiasis. Chronic Illness 2008, 4:65-79.
5. Caffrey C.R. Chemotherapy of schistosomiasis: present and future. Current Opinion in Chemical Biology 2007, 11:433-439.
6. Toure S., Zhang Y., Bosque-Oliva E., Ky C., Ouedraogo A., Koukounari A., et al. Two-year impact of single praziquantel treatment on infection in the national control programme on schistosomiasis in Burkina Faso. Bulletin of the World Health Organization 2008, 86:780-787.
7. Vennervald B.J., Booth M., Butterworth A.E., Kariuki H.C., Kadzo H., Ireri E., et al. Regression of hepatosplenomegaly in Kenyan school-aged children after praziquantel treatment and three years of greatly reduced exposure to Schistosoma mansoni. Transactions of the Royal Society of Tropical Medicine and Hygiene 2005, 99:150-160.
8. Day T.A., Botros S. Drug resistance in schistosomes. Parasitic flatworms: molecular biology, biochemistry, immunology and physiology 2006, 256-268. CAB International, Oxfordshire, UK. A. Maule, N.J. Marks (Eds.).
9. Mutapi F., Rujeni N., Bourke C., Mitchell K., Appleby L., Nausch N., et al. Schistosoma haematobium treatment in 1-5year old children: safety and efficacy of the antihelminthic drug praziquantel. PLoS Neglected Tropical Diseases 2011, 5:e1143.
10. Behbehani M., Savioli L. Report of the WHO informal consultation on monitoring of drug efficacy in the control of schistosomiasis and intestinal nematodes 1998, World Health Organization, Geneva.
11. Doenhoff M.J., Pica-Mattoccia L. Praziquantel for the treatment of schistosomiasis: its use for control in areas with endemic disease and prospects for drug resistance. Expert Review of Anti-Infective Therapy 2006, 4:199-210.
12. Wang W., Wang L., Liang Y.S. Susceptibility or resistance of praziquantel in human schistosomiasis: a review. Parasitology Research 2012, 111:1871-1877.
13. Aragon A.D., Imani R.A., Blackburn V.R., Cupit P.M., Melman S.D., Goronga T., et al. Towards an understanding of the mechanism of action of praziquantel. Molecular and Biochemical Parasitology 2009, 164:57-65.
14. Xiao S.H., Catto B.A., Webster L.T. Effects of praziquantel on different developmental stages of Schistosoma mansoni in vitro and in vivo. Journal of Infectious Diseases 1985, 151:1130-1137.
15. Sabah A.A., Fletcher C., Webbe G., Doenhoff M.J. Schistosoma mansoni: chemotherapy of infections of different ages. Experimental Parasitology 1986, 61:294-303.
16. Pica-Mattoccia L., Cioli D. Sex- and stage-related sensitivity of Schistosoma mansoni to in vivo and in vitro praziquantel treatment. International Journal for Parasitology 2004, 34:527-533.
17. Redman C.A., Robertson A., Fallon P.G., Modha J., Kusel J.R., Doenhoff M.J., et al. Praziquantel: an urgent and exciting challenge. Parasitology Today 1996, 12:14-20.
18. 2+ channels targets of praziquantel action?. International Journal for Parasitology 2005, 35:1-9.
19. Doenhoff M.J., Cioli D., Utzinger J. Praziquantel: mechanisms of action, resistance and new derivatives for schistosomiasis. Current Opinion in Infectious Diseases 2008, 21:659-667.
20. Pica-Mattoccia L., Orsini T., Basso A., Festucci A., Liberti P., Guidi A., et al. Schistosoma mansoni: lack of correlation between praziquantel-induced intra-worm calcium influx and parasite death. Experimental Parasitology 2008, 119:332-335.
21. Hu Y., Platzer E.G., Bellier A., Aroian R.V. Discovery of a highly synergistic anthelmintic combination that shows mutual hypersusceptibility. Proceedings of the National Academy of Sciences 2010, 107:5955-5960.
22. Geary T.G., Woo K., McCarthy J.S., Mackenzie C.D., Horton J., Prichard R.K., et al. Unresolved issues in anthelmintic pharmacology for helminthiases of humans. International Journal for Parasitology 2010, 40:1-13.
23. Lespine A., Alvinerie M., Vercruysse J., Prichard R.K., Geldhof P. ABC transporter modulation: a strategy to enhance the activity of macrocyclic lactone anthelmintics. Trends in Parasitology 2008, 24:293-298.
24. Liang X.J., Aszalos A. Multidrug transporters as drug targets. Current Drug Targets 2006, 7:911-921.
25. Leprohon P., Legare D., Ouellette M. ABC transporters involved in drug resistance in human parasites. Essays in Biochemistry 2011, 50:121-144.
26. Lespine A., Menez C., Bourguinat C., Prichard R.K. P-Glycoproteins and other multidrug resistance transporters in the pharmacology of anthelmintics: prospects for reversing transport-dependent anthelmintic resistance. International Journal for Parasitology: Drugs and Drug Resistance 2012, 2:58-75.
27. Kasinathan R.S., Greenberg R.M. Pharmacology and potential physiological significance of schistosome multidrug resistance transporters. Experimental Parasitology 2012, 132:2-6.
28. Higgins C.F. Multiple molecular mechanisms for multidrug resistance transporters. Nature 2007, 446:749-757.
29. Pommier Y., Pourquier P., Urasaki Y., Wu J., Laco G.S. Topoisomerase I inhibitors: selectivity and cellular resistance. Drug Resistance Updates 1999, 2:307-318.
30. Pommier Y., Sordet O., Antony S., Hayward R.L., Kohn K.W. Apoptosis defects and chemotherapy resistance: molecular interaction maps and networks. Oncogene 2004, 23:2934-2959.
31. Blackmore C.G., McNaughton P.A., Van Veen H.W. Multidrug transporters in prokaryotic and eukaryotic cells: physiological functions and transport mechanisms. Molecular Membrane Biology 2001, 18:97-103.
32. Paulsen I.T. Multidrug efflux pumps and resistance: regulation and evolution. Current Opinion in Microbiology 2003, 6:446-451.
33. van Veen H.W. Structural biology: last of the multidrug transporters. Nature 2010, 467:926-927.
34. Ventner H., Shahi S., Balakrishnan L., Velamakanni S., Bapna A., Woebking B., et al. Similarities between ATP-dependent and ion-coupled multidrug transporters. Biochemical Society Transactions 2005, 33:1008-1011.
35. Borst P., Elferink R.O. Mammalian ABC transporters in health and disease. Annual Review of Biochemistry 2002, 71:537-592.
36. Dassa E., Bouige P. The ABC of ABCs: a phylogenetic and functional classification of ABC systems in living organisms. Research in Microbiology 2001, 152:211-229.
37. Saier M.H., Paulsen I.T. Phylogeny of multidrug transporters. Seminars in Cell & Developmental Biology 2001, 12:205-213.
38. Hyde S.C., Emsley P., Hartshorn M.J., Mimmack M.M., Gileadi U., Pearce S.R., et al. Structural model of ATP-binding proteins associated with cystic fibrosis, multidrug resistance and bacterial transport. Nature 1990, 346:362-365.
39. Ambudkar S.V., Kimchi-Sarfaty C., Sauna Z.E., Gottesman M.M. P-Glycoprotein: from genomics to mechanism. Oncogene 2003, 22:7468-7485.
40. Szakacs G., Paterson J.K., Ludwig J.A., Booth-Genthe C., Gottesman M.M. Targeting multidrug resistance in cancer. Nature Reviews. Drug Discovery 2006, 5:219-234.
41. Sheps J.A., Ralph S., Zhao Z.Y., Baillie D.L., Ling V. The ABC transporter gene family of Caenorhabditis elegans has implications for the evolutionary dynamics of multidrug resistance in eukaryotes. Genome Biology 2004, 5:R15.
42. Dean M., Rzhetsky A., Allikmets R. The human ATP-binding cassette (ABC) transporter superfamily. Genome Research 2001, 11:1156-1166.
43. Annilo T., Chen Z.Q., Shulenin S., Constantino J., Thomas L., Lou H., et al. Evolution of the vertebrate ABC gene family: analysis of gene birth and death. Genomics 2006, 88:1-11.
44. Dean M., Allikmets R. Complete characterization of the human ABC gene family. Journal of Bioenergetics and Biomembranes 2001, 33:475-479.
45. Dean M., Annilo T. Evolution of the ATP-binding cassette (ABC) transporter superfamily in vertebrates. Annual Review of Genomics and Human Genetics 2005, 6:123-142.
46. van Veen H.W., Callaghan R., Soceneantu L., Sardini A., Konings W.N., Higgins C.F. A bacterial antibiotic-resistance gene that complements the human multidrug-resistance P-glycoprotein gene. Nature 1998, 391:291-295.
47. Kartner N., Riordan J.R., Ling V. Cell surface P-glycoprotein associated with multidrug resistance in mammalian cell lines. Science 1983, 221:1285-1288.
48. de Graaf D., Sharma R.C., Mechetner E.B., Schimke R.T., Roninson I.B. P-Glycoprotein confers methotrexate resistance in 3 T6 cells with deficient carrier-mediated methotrexate uptake. Proceedings of the National Academy of Sciences 1996, 93:1238-1242.
49. Pohl A., Lage H., Muller P., Pomorski T., Herrmann A. Transport of phosphatidylserine via MDR1 (multidrug resistance 1) P-glycoprotein in a human gastric carcinoma cell line. Biochemical Journal 2002, 365:259-268.
50. Mizutani T., Masuda M., Nakai E., Furumiya K., Togawa H., Nakamura Y., et al. Genuine functions of P-glycoprotein (ABCB1). Current Drug Metabolism 2008, 9:167-174.
51. Bosch I., Dunussi-Joannopoulos K., Wu R.L., Furlong S.T., Croop J. Phosphatidylcholine and phosphatidylethanolamine behave as substrates of the human MDR1 P-glycoprotein. Biochemistry 1997, 36:5685-5694.
52. Aye I.L.M.H., Singh A.T., Keelan J.A. Transport of lipids by ABC proteins: interactions and implications for cellular toxicity, viability, and function. Chemico-Biological Interactions 2009, 180:327-339.
53. Pendse S.S., Behjadi S., Schatton T., Izawa A., Sayegh M.H., Frank M.H. P-Glycoprotein functions as a differentiation switch in antigen presenting cell maturation. American Journal of Transplantation 2006, 6:2884-2893.
54. Aller S.G., Yu J., Ward A., Weng Y., Chittaboina S., Zhuo R., et al. Structure of P-glycoprotein reveals a molecular basis for poly-specific drug binding. Science 2009, 323:1718-1722.
55. Jin M.S., Oldham M.L., Zhang Q., Chen J. Crystal structure of the multidrug transporter P-glycoprotein from Caenorhabditis elegans. Nature 2012, 490:566-569.
56. Bosch I.B., Wang Z.X., Tao L.F., Shoemaker C.B. Two Schistosoma mansoni cDNAs encoding ATP-binding cassette (ABC) family proteins. Molecular and Biochemical Parasitology 1994, 65:351-356.
57. Kasinathan R.S., Goronga T., Messerli S.M., Webb T.R., Greenberg R.M. Modulation of a Schistosoma mansoni multidrug transporter by the antischistosomal drug praziquantel. The FASEB Journal 2010, 24:128-135.
58. Higgins C.F., Gottesman M.M. Is the multidrug transporter a flippase?. Trends in Biochemical Sciences 1992, 17:18-21.
59. Sharom F.J. The P-glycoprotein multidrug transporter. Essays in Biochemistry 2011, 50:161-178.
60. Gimenez-Bonafe P., Guillen Canovas A., Ambrosio S., Tortosa A., Perez-Tomas R. Drugs modulating MDR 2008, 63-99. Research Signpost, Kerala, India. N.A. Colabufo (Ed.).
61. Leier I., Jedlitschky G., Buccholz U., Cole S.P., Deeley R.G., Keppler D. The MRP gene encodes an ATP-dependent export pump for leukotriene C4 and structurally related conjugates. Journal of Biological Chemistry 1994, 269:27807-27810.
62. van de Ven R., Oerlemans R., van der Heijden J.W., Scheffer G.L., de Gruijl T.D., Jansen G., et al. ABC drug transporters and immunity: novel therapeutic targets in autoimmunity and cancer. Journal of Leukocyte Biology 2009, 86:1075-1087.
63. van de Ven R., Scheffer G.L., Scheper R.J., de Gruijl T.D. The ABC of dendritic cell development and function. Trends in Immunology 2009, 30:421-429.
64. Doyle L., Ross D.D. Multidrug resistance mediated by the breast cancer resistance protein BCRP (ABCG2). Oncogene 2003, 22:7340-7358.
65. Mealey K.L., Bentjen S.A., Gay J.M., Cantor G.H. Ivermectin sensitivity in collies is associated with a deletion mutation of the mdr1 gene. Pharmacogenetics 2001, 11:727-733.
66. Schinkel A.H., Smit J.J., van Tellingen O., Beijnen J.H., Wagenaar E., van Deemter L., et al. Disruption of the mouse mdr1a P-glycoprotein gene leads to a deficiency in the blood-brain barrier and to increased sensitivity to drugs. Cell 1994, 77:491-502.
67. Hayeshi R., Masimirembwa C., Mukanganyama S., Ungell A.L. The potential inhibitory effect of antiparasitic drugs and natural products on P-glycoprotein mediated efflux. European Journal of Pharmaceutical Sciences 2006, 29:70-81.
68. Quazi F., Molday R.S. Lipid transport by mammalian ABC proteins. Essays in Biochemistry 2011, 50:265-290.
69. Borst P., Zelcer N., van Helvoort A. ABC transporters in lipid transport. Biochimica et Biophysica Acta 2000, 1486:128-144.
70. Sundaram P., Echalier B., Han W., Hull D., Timmons L. ATP-binding cassette transporters are required for efficient RNA interference in Caenorhabditis elegans. Molecular Biology of the Cell 2006, 17:3678-3688.
71. Johnstone R.W., Ruefli A.A., Smyth M.J. Multiple physiological functions for multidrug transporter P-glycoprotein?. Trends in Biochemical Sciences 2000, 25:1-6.
72. Johnstone R.W., Ruefli A.A., Tainton K.M., Smyth M.J. A role for P-glycoprotein in regulating cell death. Leukemia & Lymphoma 2000, 38:1-11.
73. Fletcher J.I., Haber M., Henderson M.J., Norris M.D. ABC transporters in cancer: more than just drug efflux pumps. Nature Reviews. Cancer 2010, 10:147-156.
74. Borst P., van Blitterswijk W.J., Borst J., Tepper A.D., Schinkel A.H. New physiological functions for drug-transporting P-glycoproteins?. Drug Resistance Updates 1998, 1:337-339.
75. Sarkadi B., Homolya L., Szakacs G., Varadi A. Human multidrug resistance ABCB and ABCG transporters: participation in a chemoimmunity defense system. Physiological Reviews 2006, 86:1179-1236.
76. Jones P.M., George A.M. Multidrug resistance in parasites: ABC transporters, P-glycoproteins and molecular modelling. International Journal for Parasitology 2005, 35:555-566.
77. Kerboeuf D., Blackhall W., Kaminsky R., von Samson-Himmelstjerna G. P-Glycoprotein in helminths: function and perspectives for anthelmintic treatment and reversal of resistance. International Journal of Antimicrobial Agents 2003, 22:332-346.
78. James C.E., Hudson A.L., Davey M.W. Drug resistance mechanisms in helminths: is it survival of the fittest?. Trends in Parasitology 2009, 25:328-335.
79. Zutz A., Gompf S., Schagger H., Tampe R. Mitochondrial ABC proteins in health and disease. Biochimica et Biophysica Acta 2009, 1787:681-690.
80. Liesa M., Qiu W., Shirihai O.S. Mitochondrial ABC transporters function: the role of ABCB10 (ABC-me) as a novel player in cellular handling of reactive oxygen species. Biochimica et Biophysica Acta 1823, 2012:1945-1957.
81. Berriman M., Haas B.J., LoVerde P.T., Wilson R.A., Dillon G.P., Cerqueira G.C., et al. The genome of the blood fluke Schistosoma mansoni. Nature 2009, 460:352-358.
82. Protasio A.V., Tsai I.J., Babbage A., Nichol S., Hunt M., Aslett M.A., et al. A systematically improved high quality genome and transcriptome of the human blood fluke Schistosoma mansoni. PLoS Neglected Tropical Diseases 2012, 6:e1455.
83. Schistosoma japonicum genome sequencing and functional analysis consortium. The Schistosoma japonicum genome reveals features of host-parasite interplay. Nature 2009, 460:345-351.
84. Kim W.S., Weickert C.S., Garner B. Role of ATP-binding cassette transporters in brain lipid transport and neurological disease. Journal of Neurochemistry 2008, 104:1145-1166.
85. van Meer G., Halter D., Sprong H., Somerharju P., Egmond M.R. ABC lipid transporters: extruders, flippases, or flopless activators?. FEBS Letters 2006, 580:1171-1177.
86. Piehler A.P., Ozcurumez M., Kaminski W.E. A-subclass ATP-binding cassette proteins in brain lipid homeostasis and neurodegeneration. Frontiers in Psychiatry 2012, 3:17.
87. Kumkate S., Chunchob S., Janvilisri T. Expression of ATP-binding cassette multidrug transporters in the giant liver fluke Fasciola gigantica and their possible involvement in the transport of bile salts and anthelmintics. Molecular and Cellular Biochemistry 2008, 317:77-84.
88. Wilkinson R., Law C.J., Hoey E.M., Fairweather I., Brennan G.P., Trudgett A. An amino acid substitution in Fasciola hepatica P-glycoprotein from triclabendazole-resistant and triclabendazole-susceptible populations. Molecular and Biochemical Parasitology 2012, 186:69-72.
89. Olson P.D., Zarowiecki M., Kiss F., Brehm K. Cestode genomics - progress and prospects for advancing basic and applied aspects of flatworm biology. Parasite Immunology 2012, 34:130-150.
90. Robb S.M., Ross E., Sanchez Alvarado A. SmedGD: the Schmidtea mediterranea genome database. Nucleic Acids Research 2008, 36:599-606.
91. Sato H., Kusel J.R., Thornhill J. Excretion of fluorescent substrates of mammalian multidrug resistance-associated protein (MRP) in the Schistosoma mansoni excretory system. Parasitology 2004, 128:43-52.
92. Sato H., Kusel J.R., Thornhill J. Functional visualization of the excretory system of adult Schistosoma mansoni by the fluorescent marker resorufin. Parasitology 2002, 125:527-535.
93. Kusel J.R., McVeigh P., Thornhill J.A. The schistosome excretory system: a key to regulation of metabolism, drug excretion and host interaction. Trends in Parasitology 2009, 25:353-358.
94. Kusel J.R., Oliveira F.A., Todd M., Ronketti F., Lima S.F., Mattos A.C., et al. The effects of drugs, ions, and poly-l-lysine on the excretory system of Schistosoma mansoni. Memorias do Instituto Oswaldo Cruz 2006, 101:293-298.
95. Oliveira F.A., Kusel J.R., Ribeiro F., Coelho P.M. Responses of the surface membrane and excretory system of Schistosoma mansoni to damage and to treatment with praziquantel and other biomolecules. Parasitology 2006, 132:321-330.
96. Couto F.F., Coelho P.M., Araujo N., Kusel J.R., Katz N., Mattos A.C. Use of fluorescent probes as a useful tool to identify resistant Schistosoma mansoni isolates to praziquantel. Parasitology 2010, 137:1791-1797.
97. Kasinathan R.S., Morgan W.M., Greenberg R.M. Schistosoma mansoni express higher levels of multidrug resistance-associated protein 1 (SmMRP1) in juvenile worms and in response to praziquantel. Molecular and Biochemical Parasitology 2010, 173:25-31.
98. Messerli S.M., Kasinathan R.S., Morgan W., Spranger S., Greenberg R.M. Schistosoma mansoni P-glycoprotein levels increase in response to praziquantel exposure and correlate with reduced praziquantel susceptibility. Molecular and Biochemical Parasitology 2009, 167:54-59.
99. Ismail M., Metwally A., Farghaly A., Bruce J., Tao L.F., Bennett J.L. Characterization of isolates of Schistosoma mansoni from Egyptian villagers that tolerate high doses of praziquantel. The American Journal of Tropical Medicine and Hygiene 1996, 55:214-218.
100. Walter M, Kuris A. Methods for the inhibition of egg production in trematodes. US Patent Number 6,514,963 B2, 2003.
101. Safa A.R. Photoaffinity labeling of the multidrug-resistance-related P-glycoprotein with photoactive analogs of verapamil. Proceedings of the National Academy of Sciences 1988, 85:187-191.
102. Yang C.P., Mellado W., Horwitz S.B. Azidopine photoaffinity labeling of multidrug resistance-associated glycoproteins. Biochemical Pharmacology 1988, 37:1417-1421.
103. Cornwell M.M., Pastan I., Gottesman M.M. Certain calcium channel blockers bind specifically to multidrug-resistant human KB carcinoma membrane vesicles and inhibit drug binding to P-glycoprotein. Journal of Biological Chemistry 1987, 262:2166-2170.
104. Kasinathan R.S., Morgan W.M., Greenberg R.M. Genetic knockdown and pharmacological inhibition of parasite multidrug resistance transporters disrupts egg production in Schistosoma mansoni. PLoS Neglected Tropical Diseases 2011, 5:e1425.
105. Coley H.M. Overcoming multidrug resistance in cancer: clinical studies of P-glycoprotein inhibitors. Methods in Molecular Biology 2010, 596:341-358.
106. Shukla S., Wu C.P., Ambudkar S.V. Development of inhibitors of ATP-binding cassette drug transporters: present status and challenges. Expert Opinion on Drug Metabolism & Toxicology 2008, 4:205-223.
107. Xu M., Molento M., Blackhall W., Ribeiro P., Beech R., Prichard R. Ivermectin resistance in nematodes may be caused by alteration of P-glycoprotein homolog. Molecular and Biochemical Parasitology 1998, 91:327-335.
108. Molento M.B., Prichard R.K. Effects of the multidrug-resistance-reversing agents verapamil and CL 347,099 on the efficacy of ivermectin or moxidectin against unselected and drug-selected strains of Haemonchus contortus in jirds (Meriones unguiculatus). Parasitology Research 1999, 85:1007-1011.
109. Bartley D.J., McAllister H., Bartley Y., Dupuy J., Menez C., Alvinerie M., et al. P-Glycoprotein interfering agents potentiate ivermectin susceptibility in ivermectin sensitive and resistant isolates of Teladorsagia circumcincta and Haemonchus contortus. Parasitology 2009, 136:1081-1088.
110. Tompkins J.B., Stitt L.E., Morrissette A.M., Ardelli B.F. The role of Brugia malayi ATP-binding cassette (ABC) transporters in potentiating drug sensitivity. Parasitology Research 2011, 109:1311-1322.
111. Ardelli B.F., Prichard R.K. Inhibition of P-glycoprotein enhances sensitivity of Caenorhabditis elegans to ivermectin. Veterinary Parasitology 2013, 191:264-275.
112. Demeler J., Krucken J., Algusbi S., Ramunke S., De Graef J., Kerboeuf D., Geldhof P., Pomroy W.E., von Samson-Himmelstjerna G. Potential contribution of P-glycoproteins to macrocyclic lactone resistance in the cattle parasitic nematode Cooperia oncophora. Molecular and Biochemical Parasitology 2013, 188:10-19.
113. Lambert C., Leonard N., De Bolle X., Depiereux E. ESyPred3D: prediction of proteins 3D structures. Bioinformatics 2002, 18:1250-1256.